Chandreyee Das, Author at QuartzBio

About Chandreyee Das

This author has not written his bio yet.
But we are proud to say that Chandreyee Das contributed 14 entries already.

Entries by Chandreyee Das

QuartzBio Business Value Info Sheet (PDF)

Read this 1-page info sheet highlighting a case study showing how QuartzBio delivers 10x faster insights, enabling quicker study closures and better data quality — with no added headcount required.

Revealing the true costs of ICH E6(R3) compliance & noncompliance

Request our white paper to see our breakdown of the costs associated with achieving and maintaining compliance using traditional processes and point solutions. You’ll also learn how QuartzBio’s platform approach transforms compliance processes, helping customers lower costs immediately, reducing compliance issues and data problems by over 80%.

2025 Innovation Summits: Request Your Invite

We are hosting Innovation Summits on the East and West coast this fall where we gather input from Sponsor teams in translational research, biomarker / biospecimen operations, data science, R&D IT, bioinformatics, and others.

Join QuartzBio at BiotechX 2025: Explore Precision Medicine AI Agents

Attending the BiotechX USA conference in Philadelphia? It’s the premier conference for R&D teams who understand the impact of digital transformation across the entire precision medicine value chain. Stop by booth #603 to chat with QuartzBio’s Precision Medicine AI Agents. We’ll demonstrate how our AI agents act as secure, personalized virtual assistants, delivering Sample and Biomarker Intelligence Solutions for translational research, informatics, sample/biomarker operations, and IT teams.

QuartzBio Platform Version 12.0.0: Large File Support, Dynamic Analytics, Richer Clinical Insights

Learn more about the release of version 12.0.0 of QuartzBio’s Precision Medicine AI Agent Platform, featuring enhancements to our Sample Intelligence Solution, our Biomarker Intelligence Solution, and improvements to the underlying data management layer. New capabilities include large file support, dynamic analytics, and richer clinical insights.

What’s your ICH E6(R3) Readiness Score?

The new ICH E6(R3) GCP guideline, impacting clinical studies starting 23 July 2025, introduces significantly more detailed requirements around the integrity and governance of data assets and trial records, including biospecimens, their derivatives, and all associated clinical and assay data generated during trials. To help precision medicine teams ensure they meet these new requirements, we have developed this compliance checklist.

QuartzBio Platform Version 11.0.0: Dashboard Time-Savers, Organizational Sharing, Statistical Analysis

This month, we released version 11.0.0 of QuartzBio’s Precision Medicine AI Agent Platform, featuring enhancements to our Sample Intelligence Solution, our Biomarker Intelligence Solution, and performance improvements to our data management layer.

The Dawn of the Frontier Firm: How AI Agents Are Reshaping Work & Precision Medicine

I just read Microsoft’s latest Work Trend Index report, “The Year the Frontier Firm Is Born,” and it resonates deeply with the challenges and opportunities we’re seeing in precision medicine R&D. Read about QuartzBio’s approach and find links to additional resources on deploying precision medicine AI agents.

The Precision Medicine AI Agent Network: Intelligence at Scale

Watch Tobi Guennel, Ph.D., QuartzBio’s Co-founder and Chief Technology Officer, demonstrate how a network of domain-specific AI agents, orchestrated by our first-in-class Precision Medicine Virtual Assistant, empowers informatics, translational, and IT teams to conversationally explore and visualize clinical, sample, and biomarker data. The Precision Medicine AI Agent network can perform tasks semi-autonomously based on expected events and observed data trends.

Webinar: Precision Medicine AI Agents Accelerate Data-to-Insights

Join this webinar to learn how to use QuartzBio’s Precision Medicine AI Agent Platform. You can ask questions, get answers, and gain insights at the speed of decision-making.Domain-specific AI agents, orchestrated by our Precision Medicine Virtual Assistant, enable operations, translational, and informatics teams to conversationally interact with a connected ecosystem of biomarker, sample, and clinical data.